Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
161.21
+4.05 (2.58%)
At close: May 28, 2025, 4:00 PM
163.00
+1.79 (1.11%)
After-hours: May 28, 2025, 7:23 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Insurance Carriers | 1.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Insurance Carriers Growth | 57.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Partners | 97.77M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Partners Growth | 1.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Patients | 29.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Patients Growth | 8.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| United States | 1.79B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 52.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas, excluding US | 6.83M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas, excluding US Growth | 30.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe, Middle East, India, Africa | 24.76M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe, Middle East, India, Africa Growth | 8.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific and Other | 8.78M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific and Other Growth | 30.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Tests Processed | 3.18M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tests Processed Growth | 16.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tests Accessioned | 3.12M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tests Accessioned Growth | 16.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tests Reported in Laboratory | 3.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tests Reported in Laboratory Growth | 19.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tests Reported | 3.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tests Reported Growth | 18.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|